Opyl Ltd. ( (AU:OPL) ) has shared an announcement.
Opyl Limited has issued clarifications and retractions regarding its January 2025 Investor Presentation, following discussions with the ASX. The company emphasized that several statements in the presentation, including potential revenue figures, client savings, sales targets, and asset under management targets, were not intended as financial forecasts. These statements have been fully retracted, and investors are advised not to rely on them as forecasts. Opyl Limited reiterated its commitment to providing forecasts only when reasonable grounds exist, in compliance with ASIC policies.
More about Opyl Ltd.
Opyl Limited is an AI company focused on using data and technology to revolutionize clinical trials and medical research. The company is committed to innovation and strategic growth, aiming to lead in the development of future healthcare solutions.
YTD Price Performance: -15.00%
Average Trading Volume: 209,024
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: A$3.67M
For a thorough assessment of OPL stock, go to TipRanks’ Stock Analysis page.